Lipsovir cream filed for treating and preventing cold sores
This article was originally published in Scrip
Medivir's proprietary cream formulation of aciclovir and hydrocortisone, Lipsovir, has been submitted for marketing approval in the EU and, earlier this month, in the US, for the prevention and treatment of cold sores.
You may also be interested in...
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements
The SEEK spin-out ConserV Bioscience is developing a broad-spectrum coronavirus vaccine, aiming to get ahead of the arrival of new strains of the virus.